US EditionPublished • loading... • Updated
AstraZeneca to invest $2B in Maryland manufacturing expansion, creating 300 jobs
The $2 billion investment will nearly double AstraZeneca's commercial manufacturing capacity and create 2,600 skilled and construction jobs, strengthening the U.S. medicine supply chain.
- On Friday, AstraZeneca announced a $2 billion investment to expand manufacturing in Maryland, including Frederick's biologics facility and a new clinical plant in Gaithersburg, supporting 2,600 jobs.
- Planned expansion will nearly double Frederick facility's commercial capacity and begin rare disease portfolio production; officials said it strengthens the U.S. medicine supply chain and fits AstraZeneca's $50 billion U.S. investment.
- The company said it is investing about $1.81 billion in capital expenditures, with Frederick creating 200 skilled jobs and 900 construction roles while Gaithersburg adds 100 jobs, retains 400 roles, and supports 1,000 construction jobs.
- Officials said the investment strengthens the U.S. medicine supply chain, and both facilities are expected to be operational in 2029 while meeting environmental standards using AI, automation and data analytics.
- `This is the single largest private investment in the state of Maryland in at least the past 10 years`, Gov. Wes Moore said as AstraZeneca's footprint includes over 25,000 U.S. employees supporting more than 100,000 jobs.
Insights by Ground AI
22 Articles
22 Articles
Updated: Governor announces $2B AstraZeneca expansion in Frederick, Montgomery counties
Gov. Wes Moore announced in Frederick on Friday that AstraZeneca plans to invest nearly $2 billion in expanding its bio-pharmaceutical manufacturing capacity in Frederick and Montgomery counties.
·Georgia, United States
Read Full Article
Coverage Details
Total News Sources22
Leaning Left1Leaning Right2Center4Last UpdatedBias Distribution57% Center
Bias Distribution
- 57% of the sources are Center
57% Center
14%
C 57%
R 29%
Factuality
To view factuality data please Upgrade to Premium
